Gupta Sushil, Gudapati Ramesh, Gaurav Kumar, Bhise Manoj
Department of Endocrinology, Sanjay Gandhi PGI, Lucknow, India.
Indian J Endocrinol Metab. 2013 Sep;17(5):806-14. doi: 10.4103/2230-8210.117212.
Cardiovascular disease (CVD) is globally considered as the leading cause of death with 80% of CVD related deaths being reported from low and middle income countries like India. The relatively early onset age of CVD in India in comparison to Western countries also implies that most productive ages of the patient's life are lost fighting the disease. Conventional cardiovascular risk is attributed to lifestyle changes and altered metabolic activity. This forms the basis of a 10-year risk prediction score inspired by the Framingham study. Since South Asians display considerable heterogeneity in risk factors as compared to developed countries, there is a need to identify risk factors which would not only help in primary prevention but also prevent their recurrence. We reviewed published data on novel risk factors and their potential to identify cardiovascular risk at an early stage, with special emphasis on the Indian population. Emerging risk factors were reviewed to identify their potential to prevent CVD progression independently as well as in association with other cardiovascular risk factors. The most commonly studied emerging cardiovascular risk factors included coronary artery calcium score, lipoprotein (a), apolipoproteins, homocysteine, thrombosis markers like fibrinogen, and plasminogen activator inhibitor 1, carotid intima-media thickness, genotypic variations, non-alcoholic fatty liver disease, C-reactive protein, platelets, and birth weight levels. Nonetheless, more studies on large sample size can ascertain the utility of these risk factors in estimation and analysis of cardiovascular risk especially in the Indian context.
心血管疾病(CVD)在全球范围内被视为主要死因,80%的CVD相关死亡报告来自印度等低收入和中等收入国家。与西方国家相比,印度CVD的发病年龄相对较早,这也意味着患者生命中大部分有生产力的年龄段都在与疾病作斗争中丧失。传统的心血管风险归因于生活方式的改变和代谢活动的改变。这构成了受弗雷明汉姆研究启发的10年风险预测评分的基础。由于与发达国家相比,南亚人在风险因素方面表现出相当大的异质性,因此有必要识别不仅有助于一级预防而且能预防其复发的风险因素。我们回顾了关于新风险因素及其在早期识别心血管风险潜力的已发表数据,特别强调了印度人群。对新兴风险因素进行了回顾,以确定它们独立以及与其他心血管风险因素联合预防CVD进展的潜力。最常研究的新兴心血管风险因素包括冠状动脉钙化评分、脂蛋白(a)、载脂蛋白、同型半胱氨酸、血栓形成标志物如纤维蛋白原和纤溶酶原激活物抑制剂1、颈动脉内膜中层厚度、基因变异、非酒精性脂肪性肝病、C反应蛋白、血小板和出生体重水平。尽管如此,更多大样本量的研究可以确定这些风险因素在心血管风险评估和分析中的效用,特别是在印度背景下。